Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells
Publication
, Conference
Devi, GR; Oldenkamp, JR; Iversen, PL
Published in: CANCER GENE THERAPY
December 1, 2001
Duke Scholars
Published In
CANCER GENE THERAPY
ISSN
0929-1903
Publication Date
December 1, 2001
Volume
8
Start / End Page
S6 / S6
Publisher
NATURE PUBLISHING GROUP
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Devi, G. R., Oldenkamp, J. R., & Iversen, P. L. (2001). Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells. In CANCER GENE THERAPY (Vol. 8, pp. S6–S6). NATURE PUBLISHING GROUP.
Devi, G. R., J. R. Oldenkamp, and P. L. Iversen. “Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.” In CANCER GENE THERAPY, 8:S6–S6. NATURE PUBLISHING GROUP, 2001.
Devi GR, Oldenkamp JR, Iversen PL. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells. In: CANCER GENE THERAPY. NATURE PUBLISHING GROUP; 2001. p. S6–S6.
Devi, G. R., et al. “Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.” CANCER GENE THERAPY, vol. 8, NATURE PUBLISHING GROUP, 2001, pp. S6–S6.
Devi GR, Oldenkamp JR, Iversen PL. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells. CANCER GENE THERAPY. NATURE PUBLISHING GROUP; 2001. p. S6–S6.
Published In
CANCER GENE THERAPY
ISSN
0929-1903
Publication Date
December 1, 2001
Volume
8
Start / End Page
S6 / S6
Publisher
NATURE PUBLISHING GROUP
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis